196 related articles for article (PubMed ID: 16085161)
1. Diagnostic and therapeutic advances in growth hormone insensitivity.
David A; Metherell LA; Clark AJ; Camacho-Hübner C; Savage MO
Endocrinol Metab Clin North Am; 2005 Sep; 34(3):581-95, viii. PubMed ID: 16085161
[TBL] [Abstract][Full Text] [Related]
2. Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders.
Savage MO; Attie KM; David A; Metherell LA; Clark AJ; Camacho-Hübner C
Nat Clin Pract Endocrinol Metab; 2006 Jul; 2(7):395-407. PubMed ID: 16932322
[TBL] [Abstract][Full Text] [Related]
3. A half-century of studies of growth hormone insensitivity/Laron syndrome: A historical perspective.
Rosenbloom AL
Growth Horm IGF Res; 2016 Jun; 28():46-50. PubMed ID: 26276451
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity).
Laron Z
Pediatr Endocrinol Rev; 2008 Mar; 5(3):766-71. PubMed ID: 18367997
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic applications of the insulin-like growth factors.
Savage MO; Camacho-Hübner C; Dunger DB
Growth Horm IGF Res; 2004 Aug; 14(4):301-8. PubMed ID: 15231299
[TBL] [Abstract][Full Text] [Related]
6. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options.
Kemp SF
BioDrugs; 2009; 23(3):155-63. PubMed ID: 19627167
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and growth hormone receptor gene mutations of patients with Laron syndrome from a Chinese family.
Ying YQ; Wei H; Cao LZ; Lu JJ; Luo XP
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):335-8. PubMed ID: 17706034
[TBL] [Abstract][Full Text] [Related]
9. A novel exonic GHR splicing mutation (c.784G > C) in a patient with classical growth hormone insensitivity syndrome.
Akıncı A; Rosenfeld RG; Hwa V
Horm Res Paediatr; 2013; 79(1):32-8. PubMed ID: 23006617
[TBL] [Abstract][Full Text] [Related]
10. [Short stature investigation: clinical, laboratorial and genetic aspects concerning the growth hormone insensitivity (GHI)].
Jorge AA
Arq Bras Endocrinol Metabol; 2008 Aug; 52(6):1056-65. PubMed ID: 18820818
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone insensitivity: diagnostic and therapeutic approaches.
Kurtoğlu S; Hatipoglu N
J Endocrinol Invest; 2016 Jan; 39(1):19-28. PubMed ID: 26062520
[TBL] [Abstract][Full Text] [Related]
12. Therapy with recombinant human IGF-1 for children with primary insulin-like growth factor-I deficiency.
Backeljauw P
Growth Horm IGF Res; 2020 Apr; 51():22-26. PubMed ID: 31982729
[TBL] [Abstract][Full Text] [Related]
13. [New molecular mechanisms of growth hormone insensitivity].
Edouard T; Raynal P; Yart A; Conte-Auriol F; Salles JP; Tauber M
Arch Pediatr; 2008 Feb; 15(2):179-88. PubMed ID: 18207712
[TBL] [Abstract][Full Text] [Related]
14. Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature.
Guevara-Aguirre J; Rosenbloom AL; Guevara-Aguirre M; Yariz K; Saavedra J; Baumbach L; Shuster J
Growth Horm IGF Res; 2007 Jun; 17(3):261-4. PubMed ID: 17350302
[TBL] [Abstract][Full Text] [Related]
15. Epilogue: The future of Laron syndrome - The need for changes.
Laron Z
Growth Horm IGF Res; 2016 Jun; 28():79-80. PubMed ID: 26283274
[No Abstract] [Full Text] [Related]
16. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
Ranke MB
Trends Endocrinol Metab; 2005; 16(4):190-7. PubMed ID: 15860416
[TBL] [Abstract][Full Text] [Related]
17. A novel GHR intronic variant, c.266+83G>T , activates a cryptic 5' splice site causing severe GHR deficiency and classical GH insensitivity syndrome.
Feigerlova E; Swinyard M; Derr MA; Farnsworth J; Andrew SF; Rosenfeld RG; Hwa V
Horm Res Paediatr; 2013; 80(6):397-405. PubMed ID: 24296660
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human insulin-like growth factor I (rhIGF-I) and rhIGF-I/rhIGF-binding-protein-3: new growth treatment options?
Rosenbloom AL
J Pediatr; 2007 Jan; 150(1):7-11. PubMed ID: 17188604
[No Abstract] [Full Text] [Related]
19. [Laron type dwarfism].
Okimura Y
Nihon Rinsho; 2006 May; Suppl 1():94-7. PubMed ID: 16776102
[No Abstract] [Full Text] [Related]
20. Phenotypic spectrum and responses to recombinant human IGF1 (rhIGF1) therapy in patients with homozygous intronic pseudoexon growth hormone receptor mutation.
Chatterjee S; Shapiro L; Rose SJ; Mushtaq T; Clayton PE; Ten SB; Bhangoo A; Kumbattae U; Dias R; Savage MO; Metherell LA; Storr HL
Eur J Endocrinol; 2018 May; 178(5):481-489. PubMed ID: 29500309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
